EC
KDNY
EcoR1 Capital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-445,550
| Closed | -$10.3M | – | 66 |
|
|
2023
Q1 | $10.3M | Sell |
445,550
-244,450
| -35% | -$5.66M | 0.33% | 32 |
|
|
2022
Q4 | $18.1M | Hold |
690,000
| – | – | 0.55% | 31 |
|
|
2022
Q3 | $13.6M | Hold |
690,000
| – | – | 0.4% | 33 |
|
|
2022
Q2 | $12.1M | Hold |
690,000
| – | – | 0.42% | 36 |
|
|
2022
Q1 | $11.3M | Buy |
+690,000
| New | +$11.3M | 0.35% | 41 |
|
|
2021
Q3 | – | Sell |
-931,650
| Closed | -$13.2M | – | 80 |
|
|
2021
Q2 | $13.2M | Sell |
931,650
-318,351
| -25% | -$4.5M | 0.49% | 31 |
|
|
2021
Q1 | $19.4M | Hold |
1,250,001
| – | – | 0.86% | 25 |
|
|
2020
Q4 | $19.8M | Buy |
+1,250,001
| New | +$19.8M | 1.07% | 21 |
|
|
2019
Q3 | – | Sell |
-1,761,421
| Closed | -$2.71M | – | 44 |
|
|
2019
Q2 | $2.71M | Sell |
1,761,421
-177,969
| -9% | -$274K | 0.27% | 32 |
|
|
2019
Q1 | $7.72M | Buy |
+1,939,390
| New | +$7.72M | 0.71% | 28 |
|